NYSE International 100
|
9 239,94
|
-27,80
|
-0,30 %
|
Analysen zu NYSE International 100-Werten
| 09.01.24 | GSK Equal Weight | Barclays Capital | |
| 09.01.24 | Siemens Outperform | Bernstein Research | |
| 09.01.24 | GSK Sell | UBS AG | |
| 09.01.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 09.01.24 | Philips Underweight | JP Morgan Chase & Co. | |
| 09.01.24 | Rio Tinto Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.01.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 08.01.24 | Shell Overweight | JP Morgan Chase & Co. | |
| 08.01.24 | Diageo Outperform | Bernstein Research | |
| 08.01.24 | Shell Outperform | RBC Capital Markets | |
| 08.01.24 | Novartis Neutral | UBS AG | |
| 08.01.24 | Rio Tinto Neutral | UBS AG | |
| 08.01.24 | Shell Buy | Jefferies & Company Inc. | |
| 08.01.24 | Shell Overweight | Barclays Capital | |
| 08.01.24 | Sanofi Overweight | Barclays Capital | |
| 08.01.24 | Shell Buy | UBS AG | |
| 08.01.24 | Philips Equal-weight | Morgan Stanley | |
| 08.01.24 | HSBC Holdings Buy | Jefferies & Company Inc. | |
| 05.01.24 | UBS Outperform | RBC Capital Markets | |
| 05.01.24 | Deutsche Bank Outperform | RBC Capital Markets | |
| 05.01.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 05.01.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 05.01.24 | Novartis Buy | Deutsche Bank AG | |
| 04.01.24 | BP Overweight | Barclays Capital | |
| 04.01.24 | TotalEnergies Overweight | Barclays Capital | |
| 04.01.24 | Shell Overweight | Barclays Capital | |
| 04.01.24 | Eni Overweight | Barclays Capital | |
| 04.01.24 | SAP Overweight | Barclays Capital | |
| 04.01.24 | ABB Market-Perform | Bernstein Research | |
| 04.01.24 | TotalEnergies Sector Perform | RBC Capital Markets | |
| 04.01.24 | Eni Sector Perform | RBC Capital Markets | |
| 04.01.24 | BP Outperform | RBC Capital Markets | |
| 04.01.24 | Shell Outperform | RBC Capital Markets | |
| 04.01.24 | Siemens Outperform | Bernstein Research | |
| 03.01.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 03.01.24 | Unilever Underweight | JP Morgan Chase & Co. | |
| 03.01.24 | AstraZeneca Overweight | Barclays Capital | |
| 03.01.24 | Siemens Underweight | Barclays Capital | |
| 03.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 03.01.24 | Sanofi Neutral | JP Morgan Chase & Co. |
HOT STOCKS DER LETZTEN 3 TAGE
| Rio Tinto | 9 |
| TotalEnergies | 3 |
| BP | 3 |
| Mercedes-Benz Group | 2 |
| AstraZeneca | 2 |
| Sanofi | 1 |
| ING Group | 1 |
| ABB | 1 |
| Siemens | 1 |
| Vodafone Group | 1 |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.